Prosecution Insights
Last updated: November 20, 2026

Christian L Fronda, USPTO Patent Examiner

Listed by the USPTO as FRONDA, CHRISTIAN L

Tech Center 1600 • Art Units: 1645 1651 1652 1656

This examiner grants 82% of resolved cases

Analysis

Christian L Fronda is a USPTO patent examiner in tech center 1600 and art unit 1645. The profile includes 1374 resolved cases, an allowance rate of 82.5%, and a median of 889 days to allowance. The interview lift is 14.2%, indicating a moderate recorded association between interviews and allowance outcomes.

Ketoneaid Inc., Novozymes A/S, and Alteogen Inc. are the listed companies. STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C., FOLEY & LARDNER LLP, and SUGHRUE MION, PLLC are the listed firms. The extensive record supports examiner-specific preparation, with timing relevant to portfolio planning.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

82.5%
Allow Rate
+22.5% vs TC avg
1,415
Total Applications
+14.2%
Interview Lift
889
Avg Prosecution Days
Based on 1374 resolved cases, 2023–2026

Rejection Statute Breakdown

5.2%
§101 Eligibility
7.7%
§102 Novelty
25.8%
§103 Obviousness
38.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18398165 Nucleic Acid Synthesis and Sequencing Using Tethered Nucleoside Triphosphates Final Rejection The Regents of the University of California
19051360 MICROORGANISM HAVING INCREASED ACTIVITY OF 3-METHYL-2-OXOBUTANOATE HYDROXYMETHYLTRANSFERASE, AND USE THEREOF Non-Final OA CJ CheilJedang Corporation
18739532 DETERGENT COMPOSITIONS CONTAINING ENZYMES Non-Final OA The Procter & Gamble Company
18319864 ENGINEERED THERMOPHILIC REVERSE TRANSCRIPTASE Final Rejection 10x Genomics, Inc.
18429717 MITIGATION OF THERAPEUTIC PROTEIN FRAGMENTATION DURING CELL CULTURE HARVEST PROCESSES Non-Final OA AMGEN INC.
19047328 METHODS FOR PROCESSING NUCLEIC ACID SAMPLES Non-Final OA Bio-Rad Laboratories, Inc.
19065553 METHOD FOR THE FERMENTATIVE PRODUCTION OF L-LYSINE USING C. GLUTAMICUM STRAINS EXPRESSING A HETEROLOGOUS NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE PNTAB AND HAVING AN INCREASED ACTIVITY OF A MYO-INOSITOL PERMEASE Non-Final OA Evonik Operations GmbH
18847406 ALPHA-AMYLASE VARIANT Non-Final OA KAO CORPORATION
19023584 METHODS TO MANIPULATE QUALITY ATTRIBUTES OF POLYPEPTIDES PRODUCED IN CHO CELLS Non-Final OA BRISTOL-MYERS SQUIBB COMPANY
19019935 PROCESSES FOR PRODUCING ETHANOL Non-Final OA NOVOZYMES A/S
18956701 POLYPEPTIDES HAVING LYSOZYME ACTIVITY, POLYNUCLEOTIDES ENCODING SAME AND USES AND COMPOSITIONS THEREOF Final Rejection Novozymes A/S
18896095 STABILIZED CELLULASE VARIANTS Non-Final OA Novozymes A/S
18344244 Food Composition Comprising L-Fucose Final Rejection Chr. Hansen A/S
18246060 METHOD FOR IMPROVING THE STABILITY OF A COMPOSITION COMPRISING A FLAVIN-DEPENDENT LACTATE DEHYDROGENASE Final Rejection KIKKOMAN CORPORATION
18605800 METHOD FOR PURIFYING TETANUS TOXIN OR VARIANTS THEREOF Non-Final OA SHANGHAI MICRODOM BIOTECH CO. LTD

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Christian L Fronda's allowance rate?

82.5% of resolved applications examined by Christian L Fronda were allowed (1,374 resolved cases), compared with 49.4% across Art Unit 1645 over the last five years.

Does an interview help with examiner Christian L Fronda?

This examiner's interview lift is +14.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Christian L Fronda take to allow a patent?

Applications allowed by Christian L Fronda took 889 days on average from filing to allowance.

Which art unit does examiner Christian L Fronda work in?

Christian L Fronda examines applications in Art Unit 1645 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month